Osimertinib Mesylate-impurities | Pharmaffiliates

osimertinib mesylate

Osimertinib Mesylate is used to treat locally advanced or metastatic non-small-cell lung cancer. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.Reference standards of Osimertinib Mesylate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Osimertinib Mesylate - API Standards 
    [catalogue_number] => PA 15 60000
    [category_ids] => ,78,70,82,79,80,88,
    [chemical_name] => 
    [weight] => 595.71
    [form] => C29H37N7O5S
    [cas] => 1421373-66-1
    [pslug] => 1421373-66-1-osimertinib-mesylate-api-pa1560000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 1
    [offers_name] => Spring Season Offer
    [offers_status] => 1
    [offers_start_date] => 2024-03-27
    [offers_end_date] => 2024-03-31
    [pageview] => 2
    [offers_slug] => spring-season-offer
    [offers_product_id] => 3515
    [offers_product_code] => PA 15 60000
    [offers_master_id] => 1
    [offer_percentage] => 20% OFF
    [offers_product_main_cat] => Pharmaceutical Reference Standards 
)
PA 15 60000

Osimertinib Mesylate - API Standards


  • Catalogue No.:PA 15 60000

  • CAS :

    1421373-66-1

  • Molecular Formula : C29H37N7O5S

  • Molecular Weight : 595.71